SEARCH

SEARCH BY CITATION

References

  • 1
    Annan KA: In Africa, AIDS has a Woman’s Face. New York Times, New York, NY. Epub December 29, 2002. Available at: http://www.NYTimes.com. Accessed on 20 November 2010.
  • 2
    UNAIDS, Organization WH: AIDS Epidemic Update: November 2009 (UNAIDS/09.36E/JC1700E). 2009.
  • 3
    Bambra CS: Current status of reproductive behaviour in Africa. Hum Reprod Update 1999; 5:120.
  • 4
    Dhai A: HIV and AIDS in Africa: social, political, and economic realities. Theor Med Bioeth 2008; 29:293296.
  • 5
    Vandepitte J, Lyerla R, Dallabetta G, Crabbe F, Alary M, Buve A: Estimates of the number of female sex workers in different regions of the world. Sex Transm Infect 2006; 82(Suppl. 3):iii18iii25.
  • 6
    Eaton JW, Hallett TB, Garnett GP: Concurrent sexual partnerships and primary HIV Infection: a critical interaction. AIDS Behav 2010. [Epub ahead of print].
  • 7
    Mah TL, Halperin DT: Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS Behav 2010; 14:1116; dicussion 34–37.
  • 8
    Sareen J, Pagura J, Grant B: Is intimate partner violence associated with HIV infection among women in the United States? Gen Hosp Psychiatry 2009; 31:274278.
  • 9
    Seth P, Raiford JL, Robinson LS, Wingood GM, Diclemente RJ: Intimate partner violence and other partner-related factors: correlates of sexually transmissible infections and risky sexual behaviours among young adult African American women. Sex Health 2010; 7:2530.
  • 10
    Karamagi CA, Tumwine JK, Tylleskar T, Heggenhougen K: Intimate partner violence against women in eastern Uganda: implications for HIV prevention. BMC Public Health 2006; 6:284.
  • 11
    Luginaah I, Elkins D, Maticka-Tyndale E, Landry T, Mathui M: Challenges of a pandemic: HIV/AIDS-related problems affecting Kenyan widows. Soc Sci Med 2005; 60:12191228.
  • 12
    Hunsmann M: Political determinants of variable aetiology resonance: explaining the African AIDS epidemics. Int J STD AIDS 2009; 20:834838.
  • 13
    Population and HIV/AIDS: Wall chart (United Nations publication, Sales No. E.10.XIII.9). In, United Nations, Department of Economic and Social Affairs, Population Division, 2010.
  • 14
    Jaffe H: Public health. Whatever happened to the U.S. AIDS epidemic? Science 2004; 305:12431244.
  • 15
    Campsmith ML, Rhodes P, Hall HI, Green T: HIV prevalence estimates – United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:10731076.
  • 16
    Visible Minority Groups, 2006 Counts, for Canada, Provinces and Territories – 20% Sample Data. Statistics Canada, Ottawa, ON, Canada, 2010.
  • 17
    Kenya Demographic and Health Survey 2008–09. KNBoSKaI Macro (ed). Calverton, MD, KNBS and ICF Macro, 2010.
  • 18
    Cohen CR, Montandon M, Carrico AW, Shiboski S, Bostrom A, Obure A, Kwena Z, Bailey RC, Nguti R, Bukusi EA: Association of attitudes and beliefs towards antiretroviral therapy with HIV-seroprevalence in the general population of Kisumu, Kenya. PLoS ONE 2009; 4:e4573.
  • 19
    Glynn JR, Carael M, Auvert B, Kahindo M, Chege J, Musonda R, Kaona F, Buve A: Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 2001; 15(Suppl. 4):S51S60.
  • 20
    Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M: Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118129.
  • 21
    Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, Macdonald K, Walmsley S, Rebbapragada A: The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77:3240.
  • 22
    Rebbapragada A, Kaul R: More than their sum in your parts: the mechanisms that underpin the mutually advantageous relationship between HIV and sexually transmitted infections. Drug Discov Today Dis Mech 2007; 4:237246.
  • 23
    Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217223.
  • 24
    Hladik F, McElrath MJ: Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8:447457.
  • 25
    Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG: Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 2003; 51:229240.
  • 26
    Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S, Pau CP, Young NL: HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 1995; 345:10781083.
  • 27
    Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O’Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Pena Cruz V, Chui DS, Osathanondh R, Mayer K, Lee TH, Essex M: HIV-1 Langerhans’ cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:12911293.
  • 28
    Rodriguez MA, Ding M, Ratner D, Chen Y, Tripathy SP, Kulkarni SS, Chatterjee R, Tarwater PM, Gupta P: High replication fitness and transmission efficiency of HIV-1 subtype C from India: implications for subtype C predominance. Virology 2009; 385:416424.
  • 29
    Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH: HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 2009; 23:24792484.
  • 30
    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921929.
  • 31
    Modjarrad K, Vermund SH: Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010; 10:455463.
  • 32
    Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:12401243.
  • 33
    Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367377.
  • 34
    Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722725.
  • 35
    Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, Schneider T, Hofmann J, Kucherer C, Blau O, Blau IW, Hofmann WK, Thiel E: Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:692698.
  • 36
    Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16:100103.
  • 37
    Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O’Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK: The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:14341440.
  • 38
    Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JA, Clayton DG, Todd JA: Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009; 15:11151117.
  • 39
    Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA: Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007; 21:10911101.
  • 40
    Oyugi JO, Vouriot FC, Alimonti J, Wayne S, Luo M, Land AM, Ao Z, Yao X, Sekaly RP, Elliott LJ, Simonsen JN, Ball TB, Jaoko W, Kimani J, Plummer FA, Fowke KR: A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers. J Infect Dis 2009; 199:13271334.
  • 41
    Price H, Lacap P, Tuff J, Wachihi C, Kimani J, Ball TB, Luo M, Plummer FA: A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort. AIDS 2010; 24:18131821.
  • 42
    Modjarrad K, Chamot E, Vermund SH: Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008; 22:21792185.
  • 43
    Abu-Raddad LJ, Patnaik P, Kublin JG: Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006; 314:16031606.
  • 44
    Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ Jr: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:168173.
  • 45
    Sheth PM, Danesh A, Sheung A, Rebbapragada A, Shahabi K, Kovacs C, Halpenny R, Tilley D, Mazzulli T, Macdonald K, Kelvin D, Kaul R: Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J Infect Dis 2006; 193:4548.
  • 46
    Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WL, McElrath MJ, Barnes L, Ridzon R, Corey L: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427439.
  • 47
    Cohen MS: HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 2004; 12:104107.
  • 48
    Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:7383.
  • 49
    Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS: Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 22:14931501.
  • 50
    Xu F, Sternberg MR, Gottlieb SL, Berman SM, Markowitz LE: Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years – United States, 2005–2008. MMWR Morb Mortal Wkly Rep 2010; 59:456459.
  • 51
    Remis RS, Liu J, Loutfy M, Tharao W, Rebbapragada A, Chieza L, Saunders M, Green-Walker L, Kaul R: Epidemiology of Sexually Transmitted Co-infections in HIV-positive and HIV-negative African-Caribbean Women in Toronto (Abstract #304). OHTN Research Conference Toronto, Canada, 2010.
  • 52
    Smith JS, Robinson NJ: Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186(Suppl. 1):S3S28.
  • 53
    Tolosa JE, Chaithongwongwatthana S, Daly S, Maw WW, Gaitan H, Lumbiganon P, Festin M, Chipato T, Sauvarin J, Goldenberg RL, Andrews WW, Whitney CG: The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynecol 2006; 195:11981204.
  • 54
    Ness RB, Hillier S, Richter HE, Soper DE, Stamm C, Bass DC, Sweet RL, Rice P: Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 2003; 95:201212.
  • 55
    Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, Foster JA, Forney LJ: Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007; 1:121133.
  • 56
    Kaul R, Nagelkerke NJ, Kimani J, Ngugi E, Bwayo JJ, Macdonald KS, Rebbaprgada A, Fonck K, Temmerman M, Ronald AR, Moses S: Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196:16921697.
  • 57
    Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643656.
  • 58
    Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657666.
  • 59
    McCoombe SG, Short RV: Potential HIV-1 target cells in the human penis. AIDS 2006; 20:14911495.
  • 60
    Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, Mangen FW, Kiwanuka N, Bacon MC, Lutalo T, Serwadda D, Gray RH: Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS 2009; 23:22092213.
  • 61
    McLaren PJ, Ball TB, Wachihi C, Jaoko W, Kelvin DJ, Danesh A, Kimani J, Plummer FA, Fowke KR: HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 2010; 202(Suppl. 3):S339S344.
  • 62
    Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, Reinhart TA, Rogan M, Cavert W, Miller CJ, Veazey RS, Notermans D, Little S, Danner SA, Richman DD, Havlir D, Wong J, Jordan HL, Schacker TW, Racz P, Tenner-Racz K, Letvin NL, Wolinsky S, Haase AT: Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:13531357.
  • 63
    Haase AT: Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783792.
  • 64
    Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W, Kaul R: Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008; 49:520522.
  • 65
    Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R: Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589598.
  • 66
    Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L: Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009; 15:886892.
  • 67
    Kalinkovich A, Borkow G, Weisman Z, Tsimanis A, Stein M, Bentwich Z: Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 2001; 100:107117.
  • 68
    Koesters SA, Matu L, Kiama P, Anzala O, Embree J, Plummer FA, Kimani J, Fowke KR: Elevation of immune activation in Kenyan women is associated with alterations in immune function: implications for vaccine development. J Clin Immunol 2004; 24:702709.
  • 69
    Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, Koot M, Roos MT, Schellekens PT, Miedema F, Rinke de Wit TF: Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 1999; 115:443450.
  • 70
    Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, Macdonald KS, Ngugi E, Bwayo JJ, Moses S, Kovacs C, Loutfy M, Kaul R: Co-infection with Herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 2008; 197:13941401.
  • 71
    Cohen CR, Moscicki AB, Scott ME, Ma Y, Shiboski S, Bukusi E, Daud I, Rebbapragada A, Brown J, Kaul R: Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010; 24:269274.
  • 72
    Iqbal SM, Kaul R: Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 2008; 59:4454.